Bibliography
- Nafees NM. Key issues in the pharmaceutical industry: consequences on R&D. Expert Opin Drug Discov 2009;4(1):1-5
- Golec JH, Hegde S, Vernon JA. Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending. Forthcoming in Journal of Financial and Quantitative Analysis (also NBER Working paper # w11229). 2008
- Vernon, John A. Examining the link between price regulation and pharmaceutical R&D investment. Health Econ 2005;14(1):1-17
- Stiglitz JE. Scrooge and intellectual property rights: a medical prize fund could improve the financing of drug innovation. BMJ 2006;333:1279-80